PTC Therapeutics, Inc. Area of Real Estate Property
PTC Therapeutics, Inc. (PTCT) had Area of Real Estate Property of 220.50 thousand sqft as of 2020-03-31, per its 10-Q filed 2020-04-30.
Discontinued › Notes
us-gaap:AreaOfRealEstateProperty · last filed 2020-04-30
- 2020-03-31: Area of Real Estate Property 220.50K sqft.
- 2019-12-31: Area of Real Estate Property 185.00K sqft.
- 2019-09-30: Area of Real Estate Property 185.00K sqft.
| Period end | Area of Real Estate Property |
|---|---|
| 2020-03-31 | 220.50K sqft 10-Q · filed 2020-04-30 |
| 2019-12-31 | 185.00K sqft 10-Q · filed 2020-04-30 |
| 2019-09-30 | 185.00K sqft 10-Q · filed 2019-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |